3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one

C34H37N5O4S — CID 42725829

IUPAC3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one
SMILESCCCn1c(SCC(=O)N2CCC(n3c(=O)[nH]c4ccccc43)CC2)nc(-c2ccc(OC)cc2)c1-c1ccc(OC)cc1
InChIInChI=1S/C34H37N5O4S/c1-4-19-38-32(24-11-15-27(43-3)16-12-24)31(23-9-13-26(42-2)14-10-23)36-34(38)44-22-30(40)37-20-17-25(18-21-37)39-29-8-6-5-7-28(29)35-33(39)41/h5-16,25H,4,17-22H2,1-3H3,(H,35,41)
InChIKeyAYQIOJWXWVSYKE-UHFFFAOYSA-N
MW611.77 g/mol
LogP6.24
Rot. Bonds10

About 3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one

3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one (PubChem CID 42725829) has the molecular formula C34H37N5O4S and a molecular weight of 611.77 g/mol. Its IUPAC name is 3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one.

Molecular Properties

Compound Name3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one
PubChem CID42725829
Molecular FormulaC34H37N5O4S
Molecular Weight611.77 g/mol
Exact Mass611.26
IUPAC Name3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one
SMILESCCCn1c(SCC(=O)N2CCC(n3c(=O)[nH]c4ccccc43)CC2)nc(-c2ccc(OC)cc2)c1-c1ccc(OC)cc1
InChIInChI=1S/C34H37N5O4S/c1-4-19-38-32(24-11-15-27(43-3)16-12-24)31(23-9-13-26(42-2)14-10-23)36-34(38)44-22-30(40)37-20-17-25(18-21-37)39-29-8-6-5-7-28(29)35-33(39)41/h5-16,25H,4,17-22H2,1-3H3,(H,35,41)
InChIKeyAYQIOJWXWVSYKE-UHFFFAOYSA-N
XLogP6.24
TPSA94.38 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds10
Heavy Atoms44
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500611.77
LogP ≤ 56.24
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze 3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one?
The IUPAC name of 3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one (CID 42725829) is 3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one.
What is the SMILES notation for 3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one?
The canonical SMILES for 3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one is CCCn1c(SCC(=O)N2CCC(n3c(=O)[nH]c4ccccc43)CC2)nc(-c2ccc(OC)cc2)c1-c1ccc(OC)cc1.
What is the InChIKey of 3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one?
The InChIKey is AYQIOJWXWVSYKE-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H37N5O4S/c1-4-19-38-32(24-11-15-27(43-3)16-12-24)31(23-9-13-26(42-2)14-10-23)36-34(38)44-22-30(40)37-20-17-25(18-21-37)39-29-8-6-5-7-28(29)35-33(39)41/h5-16,25H,4,17-22H2,1-3H3,(H,35,41).
What are the key properties of 3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one?
3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one has a molecular weight of 611.77 g/mol, XLogP of 6.24, 10 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[1-[2-[4,5-bis(4-methoxyphenyl)-1-propylimidazol-2-yl]sulfanylacetyl]piperidin-4-yl]-1H-benzimidazol-2-one is sourced from PubChem (CID 42725829), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).